We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN.PRA
2351
DELISTED
Allergan plc
AGN.PRA
$682K ﹤0.01%
1,164
-9,988
-90% -$6.45M
TLTD icon
2352
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$689M
$679K ﹤0.01%
9,805
VGR
2353
DELISTED
Vector Group Ltd.
VGR
$679K ﹤0.01%
47,191
-643
-1% -$8.95K
CHK
2354
DELISTED
Chesapeake Energy Corporation
CHK
$679K ﹤0.01%
857
-729
-46% -$568K
CASH icon
2355
Pathward Financial
CASH
$1.8B
$674K ﹤0.01%
21,810
-354
-2% -$10.3K
CEMB icon
2356
iShares JPMorgan EM Corporate Bond ETF
CEMB
$412M
$674K ﹤0.01%
13,219
+101
+0.8% +$5.18K
BRW
2357
Saba Capital Income & Opportunities Fund
BRW
$339M
$673K ﹤0.01%
66,407
+18,081
+37% +$185K
EVA
2358
DELISTED
Enviva Inc.
EVA
$673K ﹤0.01%
24,325
-2,962
-11% -$85.2K
JPM.WS
2359
DELISTED
JPMorgan Chase
JPM.WS
$672K ﹤0.01%
10,120
-700
-6% -$42K
KMT icon
2360
Kennametal
KMT
$2.52B
$671K ﹤0.01%
13,851
-23,919
-63% -$1.07M
MD icon
2361
Pediatrix Medical
MD
$2.2B
$671K ﹤0.01%
12,554
+7,660
+157% +$361K
IRDMB
2362
DELISTED
Iridium Communications Inc - 6.75% Series B
IRDMB
$669K ﹤0.01%
1,611
-150
-9% -$60.7K
MYD
2363
DELISTED
BlackRock MuniYield Fund
MYD
$668K ﹤0.01%
46,029
-9,278
-17% -$135K
AKS
2364
DELISTED
AK Steel Holding Corp
AKS
$666K ﹤0.01%
117,679
+75,946
+182% +$396K
HIW icon
2365
Highwoods Properties
HIW
$3.47B
$665K ﹤0.01%
13,066
+1,949
+18% +$100K
TECD
2366
DELISTED
Tech Data Corp
TECD
$665K ﹤0.01%
6,790
+54
+0.8% +$5.06K
IPXL
2367
DELISTED
Impax Laboratories, Inc.
IPXL
$665K ﹤0.01%
+39,924
New +$732K
AOK icon
2368
iShares Core Conservative Allocation ETF
AOK
$793M
$662K ﹤0.01%
+19,095
New +$661K
DOL icon
2369
WisdomTree True Developed International Fund
DOL
$845M
$660K ﹤0.01%
13,041
-1,585
-11% -$79.2K
TVTY
2370
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$660K ﹤0.01%
18,069
+1,158
+7% +$43.9K
HYS icon
2371
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
$659K ﹤0.01%
6,561
-20,094
-75% -$2.03M
MVF
2372
DELISTED
BlackRock MuniVest Fund
MVF
$654K ﹤0.01%
68,068
-2,425
-3% -$23.6K
GAP
2373
The Gap Inc
GAP
$7.37B
$654K ﹤0.01%
19,214
-10,164
-35% -$303K
CTSO icon
2374
Cytosorbents Corp
CTSO
$22.6M
$650K ﹤0.01%
100,000
+50,000
+100% +$318K
IEZ icon
2375
iShares US Oil Equipment & Services ETF
IEZ
$364M
$650K ﹤0.01%
18,104
-3,453
-16% -$116K

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.